Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,845 | 46,293 | 42,900 | 30,678 | 37,619 |
| Marketable Securities | 183,224 | 180,750 | 167,943 | 176,571 | 162,833 |
| Receivables | 8,627 | 6,673 | 8,140 | 20,911 | 6,648 |
| Inventories | 11,292 | 12,451 | 12,227 | 13,580 | 14,255 |
| Other current assets | 1,931 | 2,000 | 2,300 | 0 | 0 |
| TOTAL | $245,138 | $254,380 | $241,137 | $245,942 | $227,095 |
| Non-Current Assets | |||||
| PPE Net | 2,670 | 3,297 | 3,411 | 7,831 | 8,702 |
| Investments And Advances | 0 | 0 | 0 | 0 | 17,409 |
| Other Non-Current Assets | 460 | 460 | 460 | 460 | 460 |
| TOTAL | $3,130 | $3,757 | $3,871 | $8,291 | $26,571 |
| Total Assets | $248,268 | $258,137 | $245,008 | $254,233 | $253,666 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,325 | 3,515 | 3,620 | 3,757 | 3,398 |
| Accrued Expenses | 15,130 | 20,338 | 16,674 | 23,351 | 27,986 |
| TOTAL | $26,717 | $32,957 | $27,544 | $33,454 | $37,730 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,262 | 9,104 | 7,250 | 6,346 | 6,346 |
| Other Non-Current Liabilities | 1,922 | 2,033 | 2,136 | 2,239 | 2,341 |
| TOTAL | $50,298 | $52,383 | $42,760 | $44,387 | $46,013 |
| Total Liabilities | $77,015 | $85,340 | $70,304 | $77,841 | $83,743 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,575 | 21,542 | 21,415 | 21,390 | 21,358 |
| Common Shares | 215 | 215 | 214 | 214 | 213 |
| Retained earnings | -460,553 | -456,658 | -452,972 | -449,005 | -452,324 |
| Other shareholders' equity | -3,340 | -3,247 | -3,151 | -3,325 | -4,765 |
| TOTAL | $171,253 | $172,797 | $174,704 | $176,392 | $169,923 |
| Total Liabilities And Equity | $248,268 | $258,137 | $245,008 | $254,233 | $253,666 |